ArticleScientific reports2025
Autophagy related biomarkers in ulcerative colitis revealed by bioinformatics analysis and immune correlation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Kaempferol attenuates LPS-induced inflammatory responses in H9c2 cells through involvement of the IL-6/JAK2/STAT3 pathway.Molecular biology reports · 2026Article
- Honokiol and Magnolol Exert an Anti-Inflammatory Effect by Inhibiting JAK2/STAT3/IL17 Signalling in a Rat Model of Ulcerative Colitis: A Combination of Bioinformatics and Experimental Study.Journal of cellular and molecular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Ulcerative colitis (UC) is a chronic inflammatory bowel disease of unknown etiology characterized by abnormal mucosal immune responses and persistent intestinal inflammation. UC significantly reduces quality of life and imposes a substantial economic burden. Early diagnosis and personalized treatment are crucial for improving outcomes; however, significant challenges remain. This study aimed to identify novel molecular targets for UC treatment. Gene expression data related to UC were obtained from the Gene Expression Omnibus, and differentially expressed genes (DEGs) were identified based on the criteria P < 0.05 and |logFC| > 0.5. The DEGs were intersected with autophagy-related genes (ARGs) to explore the relationship between UC pathogenesis and autophagy. LASSO regression, random forest regression, and support vector machine-recursive feature elimination were employed to screen for differentially expressed ARGs. The robustness and generalizability of the intersected genes were validated in external datasets and mouse models, and immune infiltration was analyzed to assess the interaction between UC and the immune system. PEA15 was identified as a potential UC diagnostic marker, and the diagnostic value of SERPINA1, CASP4, and CASP1 was reconfirmed. Our findings provide new insights into the pathogenesis of UC, facilitating early diagnosis and the development of personalized therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.